Japan, Aug. 12 -- TECLISON LTD has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED CANCER THERAPY.' Other related details are as follows:

Application Number: JP,2023-219148

Category (FI): A61K39/395@D,A61K39/395@E,A61K31/09,A61K31/661,A61K31/53,A61P35/00,A61P1/00,A61P11/00,A61P1/16,A61P37/04,A61K39/395@U,A61K39/395@T

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 26, 2023

Publication Date: Feb. 9, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....